| Name | Title | Contact Details |
|---|
OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. have entered a global collaboration and licensing agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer. Apatorsen is in Phase 2 clinical development and OGX-225 is currently in pre-clinical development.
The Ontario Cannabis Retail Corporation, operating as Ontario Cannabis Store is a Crown corporation that manages a legal monopoly over online retail of recreational cannabis to consumers and wholesale distribution to privately operated brick and mortar retailers throughout the province of Ontario, Canada.
DxNA is a St George, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Action Revenue Recovery is a Monroe, LA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Sagamore Health Network, Inc. is a Carmel, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.